Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Joe Kiani"


11 mentions found


Health-tech firm Masimo , facing the imminent threat of litigation and a second proxy contest, offered a settlement to Politan Capital's Quentin Koffey on Thursday that would fill a vacant board seat with one of the activist's proposed directors. The company is trying to spin off its consumer technology division in concert with an unspecified joint-venture partner, CEO Joe Kiani said earlier this year. The settlement offer would not have been possible without the imminent resignation of current director Rolf Classon, whose departure was attributed to "personal health reasons." Koffey waged a successful proxy fight at Masimo last year earning himself and another nominee representation on Masimo's six-person board. Politan launched a second proxy fight to oust Kiani earlier this year, saying that the "absence of oversight has been damaging for shareholders."
Persons: Politan Capital's Quentin Koffey, Masimo's, Craig Reynolds, William Jellison, Joe Kiani, Koffey, Masimo, Rolf Classon, Politan, Kiani Organizations: Masimo Locations: Kiani
Politan Capital's Quentin Koffey sent a letter to Masimo CEO Joe Kiani on Wednesday, demanding information about the health-tech company's proposed spinoff of its consumer business. The purchase was a catalyst for Politan's first proxy fight at the company. Last month, Masimo said it would spin off its consumer business, spurring a rally in the stock. Koffey said in his letter that Masimo management has asked "that directors sign a non-disclosure agreement" to get access to information around the deal. The activist is also seeking information on any financial and leadership opportunities Kiani has been promised at the spinout.
Persons: Politan, Quentin Koffey, Joe Kiani, Masimo, Koffey, Kiani, Micah Young, Masimo weren't Organizations: Masimo, Sound United, Fidelity, Kiani
Kiani has just under 4 million Masimo shares, or around 7.5% of the company, according to FactSet data. Masimo shares are up 15% this year, lifting the company's market cap past $7 billion. Politan controls 8.9% of Masimo shares. Kiani, 59, pledged 2.97 million Masimo shares as of April, valued at $397 million, as collateral against "personal loans." "Rather than sell his pledged shares, Mr. Kiani increased his pledge to maintain his stock ownership."
Persons: Joe Kiani, Joe Biden, Quentin Koffey's, Kiani, Masimo, Politan Organizations: Apple, Capital Management, CNBC
Health-tech company Masimo , best known for its successful patent litigation over the Apple Watch, is facing a proxy fight for the second time in two years — from the same activist investor who now sits on the company's six-person board. The acquisition, which frustrated some investors and was seen as unrelated to Masimo's core health-tech focus, prompted Politan's first proxy fight at the company. If successful, the activist investor would control four of the company's six board seats. In the previous proxy fight, Kiani showed no desire to settle a fight with the activist fund. Politan said in its release that it hoped to avoid another proxy fight.
Persons: Quentin Koffey's, Masimo, Politan's, Politan, Darlene Solomon, Bill Jellison, Solomon, Jellison, Michelle Brennan, Koffey, Joe Kiani, Kiani, Darlene, Bill, Quentin Koffey Organizations: Apple Watch, Sound Locations: Agilent
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMasimo CEO on potential split, proxy battle and spinning off consumer businessJoe Kiani, Masimo CEO, joins 'Closing Bell: Overtime' to discuss the company spinning off its consumer business.
Persons: Joe Kiani
But it's battling problems with the Apple Watch, falling iPhone sales in China, and developer fury. All of which have put Apple in a difficult position ahead of its biggest launch in nearly a decade. AdvertisementWith the Vision Pro hitting shelves in two weeks, Apple should be laser-focused on what's set to be its most significant launch since 2014. In China, Apple's biggest international market for its smartphone, sales have plummeted in recent months. These are clearly problems Apple could do without ahead of its looming Vision Pro launch.
Persons: , Michael M, Joe Kiani, Apple, Wang Gang, Organizations: Apple, Apple Watch, Service, International Trade Commission, Appeals, Federal Circuit, Business, Bloomberg, Games, Wall Street, Vision Locations: China
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailApple's response to patent ruling is 'loaded and outrageous', says Masimo CEOJoe Kiani, Masimo CEO, joins 'Closing Bell Overtime' to talk its legal win over Apple, Apple's response, what's next for Masimo and more.
Persons: Joe Kiani, what's Organizations: Apple
A new Apple Watch Ultra 2 is displayed during the 'Wonderlust' event at the company's headquarters in Cupertino, California, U.S. September 12, 2023. Masimo's 2021 complaint said the 2020 Apple Watch Series 6, the first model with blood-oxygen monitoring capabilities, infringed its patents. Apple has since shifted some of its Apple Watch production to Vietnam. Irvine, California-based Masimo has accused Apple of stealing its technology and incorporating it into several Apple Watch models. Apple is also facing an Apple Watch import ban in a separate patent dispute with medical technology company AliveCor.
Persons: Loren Elliott, Joe Biden's, Masimo, Joe Kiani, Apple's wearables, AirPods earbuds, Blake Brittain, David Bario, Grant McCool, Bill Berkrot Organizations: Apple Watch, REUTERS, U.S . International Trade Commission, Apple, U.S ., Appeals, Federal Circuit, ITC, Thomson Locations: Cupertino , California, U.S, China, Vietnam, Irvine , California, California, Delaware, Washington
The biggest buy came from RenaissanceRE CEO Kevin O'Donnell, who bought $2.5 million worth of the insurer's stock, according to securities filings and VerityData. Kiani's roughly $1 million purchase comes after he scooped up $6 million of the stock in November and December of 2022. 1) RenaissanceRE — O'Donnell bought $2.5 million worth of shares on May 26 as part of a secondary offering. 4) Masimo — Kiani spent just over $1 million on Masimo stock on May 25, building on a $6 million purchase from late last year. 5) Driven Brands — CEO Jonathan Fitzpatrick bought nearly $1 million worth of the automotive services company's stock on Tuesday.
Persons: Kevin O'Donnell, Validus, O'Donnell, Joe Kiani, Masimo, RenaissanceRE — O'Donnell, Bernard Lanigan, Kevin Dallas, — Kiani, Jonathan Fitzpatrick Organizations: AIG, Politan, Tech, Politan Capital Locations: RenaissanceRe, VerityData
Investing app Public is partnering with civic-engagement company A Starting Point. A Starting Point was cofounded by Chris Evans, Mark Kassen, and Joe Kiani. The partnership offers Public's retail investors educational content produced by A Starting Point. Fintech Public wants its users to be better informed about public policy, and it's partnering with Captain America for the job. The series is aimed to educate retail investors by offering policy news briefs, fiscal and monetary policy explainers, and interviews with lawmakers.
The CEO of medical device company Masimo bought roughly $5 million of stock over the past week, adding to his stake shortly after a lawsuit from an activist investor. Masimo : CEO Joe Kiani made two groups of purchases worth nearly $5 million in total on Nov. 11 and Nov. 14. Corebridge Financial : director Alan Colberg bought about $688,000 worth of stock on Nov. 10. Cogent Communications : director Marc Montagner bought roughly $549,000 of stock on Nov. 9. The purchase of Cogent stock by Montagner is the largest ever insider purchase for the internet service provider.
Total: 11